MedTrace Logo

ROSCAP: Reduction of Smoking in Cardiac Patients Study

NCT00301626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2008-10-24

No results posted yet for this study

Summary

Background. The ROSCAP Study was a randomized controlled trial in heart disease patients to test the effect of a smoking reduction intervention on cigarettes per day (cpd) and biochemical and clinical indicators of tobacco exposure. .

Conditions

  • Nicotine Dependence
  • Tobacco Dependence
  • Cardiac Disease

Interventions

BEHAVIORAL

smoking reduction intervention (including NRT)

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    lead NIH

Principal Investigators

  • Anne Joseph, MD, MPH · Minneapolis VAMC & University of Minnesota

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Completion
2005-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00301626 on ClinicalTrials.gov